PhRMA Granted Summary Judgment in Challenge to Oregon Prescription Drug…
In March, the U.S. District Court for the District of Oregon issued a ruling in Pharmaceutical Research and Manufacturers of…
Author
CMS Issues CY 2025 Medicare Advantage and Part D Final Rule
On April 4, 2024, the Centers for Medicare & Medicaid Services (“CMS”) issued the contract year 2025 Medicare Advantage and…
Changes to 340B Program Finalized
The Biden administration recently issued a rule making changes to the 340B drug discount program’s dispute resolution process. The…
OPDP Considers Potential Misleading Implications of Television Ads
Recently, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) research team…
DOJ Files Complaint in Intervention Against Regeneron Pharmaceuticals in…
The United States Department of Justice (DOJ) recently intervened in a False Claims Act case against Regeneron Pharmaceuticals…
Connecticut Pharmaceutical Reporting Deadline Approaches: New FAQ Document…
With less than two weeks before the Connecticut reporting deadline for pharmaceutical companies to report representative…
Prominently Displaying Methodology of Studies Improves Physician Perception…
A recent research piece published in the Research in Social and Administrative Pharmacy by the Food and Drug Administration (FDA)…
HHS Releases White Paper on Drug Shortages, Solutions
Recently, the United States Department of Health and Human Services (HHS) issued a white paper, “Policy Considerations to Prevent…
Nurse Practitioner to Serve Prison Time for Role in Telemedicine Health…
Recently, Daphne Jenkins, a Virginia-based nurse practitioner, was sentenced to 18 months in prison followed by two years of…
Summary of Section 1557 of the Affordable Care Act and Application for…
The United States Department of Health and Human Services (HHS) has issued a final rule under Section 1557 of the Affordable Care…